Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Cash from Investing Activities (2019 - 2025)

Historic Cash from Investing Activities for Volitionrx (VNRX) over the last 9 years, with Q2 2025 value amounting to -$76783.0.

  • Volitionrx's Cash from Investing Activities rose 5214.43% to -$76783.0 in Q2 2025 from the same period last year, while for Sep 2025 it was -$276450.0, marking a year-over-year increase of 5962.55%. This contributed to the annual value of -$573852.0 for FY2024, which is 4704.94% up from last year.
  • As of Q2 2025, Volitionrx's Cash from Investing Activities stood at -$76783.0, which was up 5214.43% from -$1808.0 recorded in Q1 2025.
  • Volitionrx's 5-year Cash from Investing Activities high stood at -$1808.0 for Q1 2025, and its period low was -$578752.0 during Q4 2022.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$199225.5 (2023), whereas its average is -$237774.1.
  • Per our database at Business Quant, Volitionrx's Cash from Investing Activities tumbled by 104714.8% in 2021 and then soared by 9770.58% in 2025.
  • Volitionrx's Cash from Investing Activities (Quarter) stood at -$128572.0 in 2021, then crashed by 350.14% to -$578752.0 in 2022, then soared by 46.66% to -$308722.0 in 2023, then surged by 35.91% to -$197859.0 in 2024, then soared by 61.19% to -$76783.0 in 2025.
  • Its Cash from Investing Activities stands at -$76783.0 for Q2 2025, versus -$1808.0 for Q1 2025 and -$197859.0 for Q4 2024.